Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-19

Clinical Trial Update: Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares universal prophylaxis with posaconazole versus pre-emptive therapy after lung transplantation. The goal is to prevent fungal i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Bayside Health | Conditions: Fungal Infection | Phase 2 | Status: UNKNOWN